What did the FDA find wrong with Hangzhou Facecare Cosmetics Co., Ltd.?

The FDA issued a warning letter citing cgmp violations related to their products or manufacturing practices.

Are Hangzhou Facecare Cosmetics Co., Ltd. products safe to use?

Based on the FDA's findings, consumers should exercise caution. The company was found to have cgmp violations that may affect product safety.

What should I do if I've used Hangzhou Facecare Cosmetics Co., Ltd. products?

If you have used products from Hangzhou Facecare Cosmetics Co., Ltd. and experience any adverse effects, contact your healthcare provider immediately. You can also report adverse events to the FDA's MedWatch program.

Hangzhou Facecare Cosmetics Co., Ltd. FDA Warning (2017)

Name: Hangzhou Facecare Cosmetics Co., Ltd. FDA Warning (2017)
Creator: Supplement Safety Data Team
Published: 2026-03-27T01:44:23.727233

Compiled by the Supplement Safety Data Team | Sourced from Official FDA Records on November 17, 2017

MODERATE SEVERITY Center for Drug Evaluation and Research 2017

Disclaimer: This report is an analysis of a public FDA warning letter. It is not medical advice. If you have consumed these products and feel unwell, contact a healthcare professional immediately.

Executive Summary

The FDA issued a warning letter to Hangzhou Facecare Cosmetics Co., Ltd. on November 17, 2017 citing cgmp violations. The letter was issued by Center for Drug Evaluation and Research.

CGMP Violations

Detailed Analysis

False Claims and Regulatory Violations

The FDA identified regulatory violations in Hangzhou Facecare Cosmetics Co., Ltd.'s operations or product claims.

Potential Health Risks

Consumers should be aware of potential risks associated with products from Hangzhou Facecare Cosmetics Co., Ltd..

Regulatory Context

The quality control test methods and specifications used by your firm (or a contract laboratory) to analyze each drug product batch prior to a batch release decision.

A summary of test results obtained from testing all in-date drug products for United States distribution for identity and strength of active ingredients, and all other appropriate quality attributes (including total count and objectionable microorganisms).

A summary of your procedures (e.g., qualification, audit, delineation of responsibilities) for qualifying and overseeing the adequacy of contract facilities that test the drug products you manufacture.

Key Entities Identified

Hangzhou Facecare Cosmetics Co. Ltd. FDA Warning Letter

Frequently Asked Questions

What did the FDA find wrong with Hangzhou Facecare Cosmetics Co., Ltd.?: The FDA issued a warning letter citing cgmp violations related to their products or manufacturing practices.
Are Hangzhou Facecare Cosmetics Co., Ltd. products safe to use?: Based on the FDA's findings, consumers should exercise caution. The company was found to have cgmp violations that may affect product safety.
What should I do if I've used Hangzhou Facecare Cosmetics Co., Ltd. products?: If you have used products from Hangzhou Facecare Cosmetics Co., Ltd. and experience any adverse effects, contact your healthcare provider immediately. You can also report adverse events to the FDA's MedWatch program.

Source Document

This report is based on an official FDA warning letter. The original document is a public record.

View Original FDA Warning Letter

Medical Disclaimer: This report is an analysis of public FDA warning letters. It is not medical advice. If you have consumed these products and feel unwell, contact a healthcare professional immediately. You can report adverse events to the FDA MedWatch program.